Studies regarding the transcriptomic alterations of ANKRD22 in patients with PD are limited and the mechanisms by which ANKRD22 transcriptomic alterations contribute to neurodegenerative diseases are poorly understood. Here, ANKRD22 is linked to neurodegenerative disease.